Evidence map›Paper›PMID 26268654›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Inhibition of B Lymphopoiesis by Adipocytes and IL-1-Producing Myeloid-Derived Suppressor Cells.

Domenick E Kennedy, Katherine L Knight

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 95 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  6. Article
  7. Pathology of Diabetes-Induced Immune Dysfunction.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Targeting adipocyte-immune cell crosstalk to control breast cancer progression.Journal of cancer research and clinical oncology · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. The adaptation of SARS-CoV-2 to humans.Memorias do Instituto Oswaldo Cruz · 2022
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Domenick E KennedyDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60153.
Katherine L KnightDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60153 kknight@luc.edu.
Loyola University Chicago · US

Funding

Experimental Immunology Training GrantT32AI007508 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 1997 to 2022
$4.0M
Maintaining B cell immunity with aged B lymphocytesR01AI068390 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 2007 to 2015
$3.4M
Decline of B lymphopoiesis with Age: Adipocytes and Myeloid Suppressor CellsF31AG047817 · NIA · LOYOLA UNIVERSITY CHICAGO · PI KENNEDY, DOMENICK EDWARD · 2014 to 2015
$57k
NIAID NIH HHS AI068390NIAID NIH HHS R01 AI068390NIAID NIH HHS T32 AI007508NIA NIH HHS F31 AG047817NIA NIH HHS F31AG047817
6 · The paper itself

Abstract

B lymphopoiesis declines with age, and this decline correlates with increased adipose tissue in the bone marrow (BM). Also, adipocyte-derived factors are known to inhibit B lymphopoiesis. Using cocultures of mouse BM cells with OP9 stromal cells, we found that adipocyte-conditioned medium induces the generation of CD11b(+)Gr1(+) myeloid cells, which inhibit B cell development in vitro. Adipocyte-conditioned medium-induced CD11b(+)Gr1(+) cells express Arg1 (arginase) and Nos2 (inducible NO synthase) and suppress CD4(+) T cell proliferation, indicating that these cells are myeloid-derived suppressor cells (MDSCs). Blocking arginase and inducible NO synthase did not restore B lymphopoiesis, indicating that inhibition is not mediated by these molecules. Transwell and conditioned-medium experiments showed that MDSCs inhibit B lymphopoiesis via soluble factors, and by cytokine array we identified IL-1 as an important factor. Addition of anti-IL-1 Abs restored B lymphopoiesis in BM cultures containing MDSCs, showing that MDSC inhibition of B lymphopoiesis is mediated by IL-1. By treating hematopoietic precursors with IL-1, we found that multipotent progenitors are targets of IL-1. This study uncovers a novel function for MDSCs to inhibit B lymphopoiesis through IL-1. We suggest that inflammaging contributes to a decline of B lymphopoiesis in aged individuals, and furthermore, that MDSCs and IL-1 provide therapeutic targets for restoration of B lymphopoiesis in aged and obese individuals.

Indexed as

AdipocytesAnimalsAntibodiesArginaseB-LymphocytesBone Marrow CellsCD11b AntigenCD4-Positive T-LymphocytesCell ProliferationCells, CulturedCoculture TechniquesCulture Media, ConditionedImmunosenescenceInflammationInterleukin-1Lymphocyte ActivationAntibodiesArg1 protein, mouseArginaseCD11b AntigenCulture Media, ConditionedInterleukin-1Nitric Oxide Synthase Type IINos2 protein, mouse

Identifiers

PMID26268654
PMCPMC4561202
OpenAlexW1903506892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.